Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Hyaluronic acid to improve healing after endodontic microsurgery

Official title: Effectiveness of Using Cross-linked Hyaluronic Acid in Endodontic Microsurgery. A RCT

Run by University of Bern · NCT07501585 · Data updated 2026-11-12

This trial will test whether adding cross-linked hyaluronic acid during endodontic microsurgery helps adults with apical periodontitis of first molars heal faster and have less pain.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment46 (estimated)
SponsorUniversity of Bern
Academic / other
Drugs / interventionsChemotherapy
Locations1 site (Moscow)
StatusRecruiting
StartedFebruary 20, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedMarch 30, 2026
Trial IDNCT07501585 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with apical periodontitis of a maxillary or mandibular first molar at least 12 months after non-surgical endodontic treatment, good oral hygiene (FMPS and BoP ≤20%), a periapical lesion ≤10 mm, and a four-wall bone defect are ideal candidates.

Probably not a fit

Patients who are heavy smokers (>10 cigarettes/day), allergic to hyaluronic acid, pregnant or lactating, have uncontrolled diabetes, untreated periodontal disease, acute infections at the surgical site, or lesions/defects that do not meet the size or morphology criteria are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blinded, parallel-group trial comparing endodontic microsurgery with adjunctive cross-linked hyaluronic acid versus the same surgery without the adjunct in adults with persistent apical periodontitis of first molars. Eligible patients previously treated with non-surgical root canal therapy are allocated to test or control groups and followed for 12 months. Primary outcomes are early soft-tissue healing (Early Wound Healing Score at day 4) and postoperative pain (visual analogue scale), with secondary radiographic healing assessments at 3, 6, and 12 months including CBCT. Blinded outcome examiners evaluate radiographs to determine differences in hard-tissue healing.

Why it matters

Potential benefit: If successful, adjunctive cross-linked hyaluronic acid could speed soft- and hard-tissue healing, reduce postoperative pain, and improve the long-term stability of surgical outcomes.

How similar studies have gone: Hyaluronic acid has shown promising soft-tissue healing benefits in oral and periodontal surgery, but robust randomized evidence specifically in endodontic microsurgery is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Written informed consent
* ≥18 years of age
* Apical peridontitis at maxillar or mandibular first molars ≥ 12 months after non-surgical endodontical treatment
* Full mouth plaque score (FMPS) and bleeding score (BoP) \< or 20%
* Periapical lesion \< or 10 mm
* Four-wall bone defect morphology

Exclusion Criteria:

* Smokers of more than 10 cigarettes a day
* Allergy to hyaluronic acid
* Pregnancy or lactation
* Uncontrolled Diabetes
* Untreated periodontal conditions
* Any conditions associated with poor compliance or failure to maintain good oral hygiene
* Acute infections lesions in areas intended for surgery
* Chemotherapy and radiotherapy treatment

Where it's running

  • Praktika 1
    Moscow, Russia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.